GentiBio
BiotechnologyView the employees at
GentiBio-
Ashley Landuyt, Ph.D. Scientist II at GentiBio
-
Boston, Massachusetts, United States
-
Rising Star
Shawn Li Computational Scientist | Automation Engineer | AWS CCP | Make Tregs Better!-
Cambridge, Massachusetts, United States
-
Rising Star
Christopher S. Principal Data Engineer - Informatics, Automation & IT-
Rising Star
Aravind Kancharla Senior Associate Scientist at GentibBio-
Cambridge, Massachusetts, United States
-
Top 10%
Shivali V. Associate Scientist II @GentiBio | RA @ColumbiaMed-
New York, New York, United States
-
Rising Star
Overview
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.
-